IPO Report: ContraFect (CFRXU) – Equities.com
IPO Report: ContraFect (CFRXU)Equities.comContraFect (CFRXU) is a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases. It is headquartered in Yonkers, N.Y.. Nineteen other companies are … …read more
IPO Report: ContraFect (CFRXU) – Equities.com Read More »